Privia Health Group (PRVA) Set to Announce Earnings on Thursday

Privia Health Group (NASDAQ:PRVA) is scheduled to be posting its quarterly earnings results before the market opens on Thursday, May 9th. Analysts expect Privia Health Group to post earnings of $0.05 per share for the quarter. Privia Health Group has set its FY 2024 guidance at EPS.Investors that wish to listen to the company’s conference call can do so using this link.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.02). The company had revenue of $440.80 million during the quarter, compared to analyst estimates of $425.81 million. Privia Health Group had a net margin of 1.39% and a return on equity of 3.97%. Privia Health Group’s revenue for the quarter was up 21.0% on a year-over-year basis. During the same period in the prior year, the business earned $0.14 EPS. On average, analysts expect Privia Health Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Privia Health Group Price Performance

PRVA stock opened at $19.08 on Tuesday. Privia Health Group has a 1 year low of $17.54 and a 1 year high of $30.15. The firm has a market capitalization of $2.26 billion, a P/E ratio of 100.42, a P/E/G ratio of 2.56 and a beta of 0.81. The business’s 50-day moving average is $19.62 and its two-hundred day moving average is $21.09.

Wall Street Analysts Forecast Growth

PRVA has been the subject of several research analyst reports. JPMorgan Chase & Co. decreased their price objective on Privia Health Group from $38.00 to $30.00 and set an “overweight” rating for the company in a report on Wednesday, March 6th. Canaccord Genuity Group dropped their target price on Privia Health Group from $41.00 to $37.00 and set a “buy” rating on the stock in a research report on Tuesday, March 19th. Stifel Nicolaus cut their price target on shares of Privia Health Group from $28.00 to $24.00 and set a “buy” rating for the company in a report on Wednesday, May 1st. Jefferies Financial Group assumed coverage on Privia Health Group in a research note on Monday, February 26th. They set a “buy” rating and a $25.00 price target on the stock. Finally, Citigroup began coverage on Privia Health Group in a research note on Monday, April 22nd. They issued a “buy” rating and a $25.00 target price on the stock. Two analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $26.58.

Insider Buying and Selling

In other Privia Health Group news, CFO David Mountcastle sold 3,933 shares of the firm’s stock in a transaction dated Tuesday, April 2nd. The stock was sold at an average price of $17.77, for a total value of $69,889.41. Following the transaction, the chief financial officer now directly owns 262,279 shares of the company’s stock, valued at $4,660,697.83. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CFO David Mountcastle sold 3,933 shares of Privia Health Group stock in a transaction dated Tuesday, April 2nd. The stock was sold at an average price of $17.77, for a total transaction of $69,889.41. Following the sale, the chief financial officer now directly owns 262,279 shares of the company’s stock, valued at $4,660,697.83. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Thomas Bartrum sold 2,252 shares of Privia Health Group stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $18.42, for a total value of $41,481.84. Following the sale, the executive vice president now directly owns 103,862 shares in the company, valued at $1,913,138.04. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 31,783 shares of company stock valued at $582,886. 14.20% of the stock is currently owned by company insiders.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.